ORIC Pharmaceuticals to Present Initial Data from Ongoing Phase 1b Study of ORIC-101 in Combination with Nab-paclitaxel at the 2021 ASCO Annual Meeting

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement